[go: up one dir, main page]

GR3023938T3 - 3',5'-ditertbutyl-4'-hydroxyflavones, method for their preparation and pharmaceutical compositions with an antioxidant and antivasoconstricting activity - Google Patents

3',5'-ditertbutyl-4'-hydroxyflavones, method for their preparation and pharmaceutical compositions with an antioxidant and antivasoconstricting activity

Info

Publication number
GR3023938T3
GR3023938T3 GR970401586T GR970401586T GR3023938T3 GR 3023938 T3 GR3023938 T3 GR 3023938T3 GR 970401586 T GR970401586 T GR 970401586T GR 970401586 T GR970401586 T GR 970401586T GR 3023938 T3 GR3023938 T3 GR 3023938T3
Authority
GR
Greece
Prior art keywords
antivasoconstricting
hydroxyflavones
ditertbutyl
antioxidant
activity
Prior art date
Application number
GR970401586T
Other languages
English (en)
Inventor
Yves Rolland
Guy Lewin
Jean-Paul Vilaine
Albert Lenaers
Catherine Thollon
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of GR3023938T3 publication Critical patent/GR3023938T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GR970401586T 1992-03-31 1997-06-30 3',5'-ditertbutyl-4'-hydroxyflavones, method for their preparation and pharmaceutical compositions with an antioxidant and antivasoconstricting activity GR3023938T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9203861A FR2689127B1 (fr) 1992-03-31 1992-03-31 Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.

Publications (1)

Publication Number Publication Date
GR3023938T3 true GR3023938T3 (en) 1997-09-30

Family

ID=9428265

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970401586T GR3023938T3 (en) 1992-03-31 1997-06-30 3',5'-ditertbutyl-4'-hydroxyflavones, method for their preparation and pharmaceutical compositions with an antioxidant and antivasoconstricting activity

Country Status (13)

Country Link
US (2) US5280024A (el)
EP (1) EP0564350B1 (el)
JP (1) JPH07119221B2 (el)
AT (1) ATE153022T1 (el)
AU (1) AU655106B2 (el)
CA (1) CA2092961A1 (el)
DE (1) DE69310602T2 (el)
DK (1) DK0564350T3 (el)
ES (1) ES2104090T3 (el)
FR (1) FR2689127B1 (el)
GR (1) GR3023938T3 (el)
NZ (1) NZ247287A (el)
ZA (1) ZA932312B (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2689127B1 (fr) * 1992-03-31 1994-05-06 Adir Cie Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.
AU5259296A (en) * 1995-04-07 1996-10-23 Warner-Lambert Company Flavones and coumarins as agents for the treatment of athero sclerosis
DE19638515B4 (de) * 1996-09-20 2004-01-15 Grundig Car Intermedia System Gmbh Verfahren und Vorrichtung zur Zuordnung von Nachrichten, insbesondere Verkehrsnachrichten
FR2753969B1 (fr) * 1996-09-27 1998-10-30 Adir Nouveaux derives de flavones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6207665B1 (en) * 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US6028088A (en) * 1998-10-30 2000-02-22 The University Of Mississippi Flavonoid derivatives
EP1127572A3 (en) * 2000-02-25 2003-05-02 Basf Aktiengesellschaft Use of flavones for treating cycloxygenase-2 mediated diseases
FR2815033B1 (fr) 2000-10-06 2003-09-05 Negma Lab Derives de 7-carboxy-flavones, porcede pour leur preparation et leur application en therapeutique
US6818668B2 (en) 2002-04-12 2004-11-16 Biotest Laboratories, Llc 5-alkyl-7-alkylcarbonate-isoflavone ester and related method
GB0216371D0 (en) * 2002-07-13 2002-08-21 Rowett Res Inst The Compounds
DE10232595A1 (de) * 2002-07-18 2004-02-05 Merck Patent Gmbh Lichtschutzmittel
WO2006045096A2 (en) 2004-10-20 2006-04-27 Resverlogix Corp. Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
KR100729731B1 (ko) * 2005-07-19 2007-06-20 건국대학교 산학협력단 사람 피부 세포의 세포사멸을 억제하는 활성을 갖는플라보노이드
AU2006275514B2 (en) * 2005-07-29 2012-04-05 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
ES2454966T3 (es) 2007-02-01 2014-04-14 Resverlogix Corp. Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
SI2346837T1 (sl) 2008-06-26 2015-05-29 Resverlogix Corporation Postopki pripravljanja kinazolinonskih derivatov
JP5635535B2 (ja) 2009-01-08 2014-12-03 レスバーロジックス コーポレイション 心血管疾患の予防および治療のための化合物
NZ755378A (en) 2009-03-18 2022-07-29 Resverlogix Corp Novel quinazolinones and related compounds for use as anti-inflammatory agents
ES2821018T3 (es) 2009-04-22 2021-04-23 Resverlogix Corp Nuevos agentes antiinflamatorios
GB201017315D0 (en) 2010-10-13 2010-11-24 Antoxis Ltd Compound
US9610251B2 (en) 2011-11-01 2017-04-04 Resverlogix Corp. Pharmaceutical compositions for substituted quinazolinones
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
KR20150096794A (ko) 2012-12-21 2015-08-25 제니쓰 에피제네틱스 코포레이션 브로모도메인 저해제로서의 신규한 헤테로사이클릭 화합물
JO3789B1 (ar) 2015-03-13 2021-01-31 Resverlogix Corp التراكيب والوسائل العلاجية المعتمدة لمعالجة الامراض المتعلقة بالمتممة

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1247909A (fr) * 1955-11-02 1960-12-09 Recordati Lab Farmacologico Dr Procédé de préparation des dérivés d'hydroxychromones
DE1054091B (de) * 1958-05-30 1959-04-02 Chemiewerk Homburg Ag Verfahren zur Herstellung von N-substituierten 2-Phenyl-7-aminoalkoxy-chromonen
DE1418516A1 (de) * 1959-07-28 1968-12-05 Klosa Dipl Chem Dr Josef Verfahren zur Herstellung von Flavon-7-oxyessigsaeureamiden
GB1250388A (el) * 1968-11-27 1971-10-20
DE2029658A1 (de) * 1970-06-16 1971-12-23 Boehnnger Mannheim GmbH, 6800 Mann heim Waldhof 2 (4 Oxo-4H 1 benzopyran 7 yl) oxy isobutter saure Derivate und Verfahren zur Herstellung derselben
US3816466A (en) * 1971-12-22 1974-06-11 Warner Lambert Co Flavanoid ring systems
JPH02214780A (ja) * 1989-02-14 1990-08-27 San Ei Chem Ind Ltd アントシアン色素の安定化法
JPH035423A (ja) * 1989-06-01 1991-01-11 Ichimaru Pharcos Co Ltd フラボノイド含有過酸化脂質生成抑制剤
DE4011187A1 (de) * 1990-04-06 1991-10-10 Hoechst Ag Substituierte 3-thia- bzw. 3-oxa-alkyl-flavone, verfahren zu ihrer herstellung, verwendung derselben, arzneimittel auf basis dieser verbindungen sowie zwischenprodukte
DK0478558T3 (da) * 1990-04-06 1994-05-02 Chinoin Gyogyszer Es Vegyeszet Forbedret fremgangsmåde til fremstilling af substituerede isoflavonderivater
SG65570A1 (en) * 1992-02-25 1999-06-22 Recordati Chem Pharm Heterobicyclic compounds
FR2689127B1 (fr) * 1992-03-31 1994-05-06 Adir Cie Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.

Also Published As

Publication number Publication date
DE69310602D1 (de) 1997-06-19
US5280024A (en) 1994-01-18
CA2092961A1 (fr) 1993-10-01
DK0564350T3 (da) 1997-12-15
ZA932312B (en) 1993-10-18
ES2104090T3 (es) 1997-10-01
JPH0625212A (ja) 1994-02-01
FR2689127B1 (fr) 1994-05-06
ATE153022T1 (de) 1997-05-15
EP0564350A1 (fr) 1993-10-06
DE69310602T2 (de) 1997-12-18
NZ247287A (en) 1994-08-26
JPH07119221B2 (ja) 1995-12-20
AU3559193A (en) 1993-10-07
EP0564350B1 (fr) 1997-05-14
US5457103A (en) 1995-10-10
FR2689127A1 (fr) 1993-10-01
AU655106B2 (en) 1994-12-01

Similar Documents

Publication Publication Date Title
GR3023938T3 (en) 3',5'-ditertbutyl-4'-hydroxyflavones, method for their preparation and pharmaceutical compositions with an antioxidant and antivasoconstricting activity
IL112495A0 (en) Phenylacetic acid derivatives, their preparation and compositions containing them
DE3576690D1 (de) Pyrimidopyrimidinderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zubereitungen und ihre verwendung als anti-allergische mittel.
ZA937112B (en) 17-aryl and 17-heterocyclyl-14beta-5alpha-androstane, androstene and androstaniene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions contning same
CA2108903A1 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
ES2004386A6 (es) Un procedimiento para producir un nuevo derivado de difluorohalometoxifenilo
SG46307A1 (en) New pyrazine derivatives the preparation and use thereof
DK165109C (da) 4-anilino-cyklopentaoedaapyrimidinderivater samt farmaceutiske midler indeholdende saadanne
ES8700673A1 (es) Un procedimiento para preparar derivados de acido griseolico
GB9206768D0 (en) New compounds for use in the treatment of cancer
MY132057A (en) Quinoxalinones, a process for their preparation and their use
IL107068A0 (en) 5-oxo-dibenzo(a,d)cyclohepta-1,4-dienes,their preparation and pharmaceutical compositions containing them
EP0186023A3 (en) Biliary acid derivatives, process for their preparation and pharmaceutical compositions containing them
CA2010982A1 (en) Osteogenesis promotion with use of vitamin d derivatives
AU6826887A (en) 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates
HUT41025A (en) Process for preparing octahydro-indolizine derivatives and pharmaceutical compositions containing such compounds as active ingredients
TW282470B (el)
MY105138A (en) Anti-hypertensive sulfonanilides.
HUT65533A (en) Process for producing 2-amino-pyrimidine-4-carboxamide derivatives and pharmaceutical preparations containing them
ES550781A0 (es) Un procedimiento para preparar un derivado de 1-benzhidril--4-cinamilpiperazina
AU1032197A (en) New amino alcohol derivatives, processes for their production and pharmaceutical agents containing these compounds
HU9600300D0 (en) Thiocarbamoyl derivatives using as antimicrobial agents and process for producing of these
ES8707939A1 (es) Procedimiento para preparar derivados de n-carboxialquil-2--oxo-3-diaril-5,6-triazinas
KR910000786A (ko) 콜레스타디엔 유도체, 이의 제조방법 및 HMG-CoA 환원제를 저해하는 작용을 하는 약제로서의 이의 용도
MX9207565A (es) Hidroxilacion.